W8N Stock Overview
A biotechnology company, operates in the aquaculture industry in the United States and Canada.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
AquaBounty Technologies, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$3.40 |
| 52 Week High | US$21.06 |
| 52 Week Low | US$3.40 |
| Beta | 1.36 |
| 1 Month Change | 0% |
| 3 Month Change | -9.37% |
| 1 Year Change | -80.26% |
| 3 Year Change | -98.11% |
| 5 Year Change | n/a |
| Change since IPO | -96.37% |
Recent News & Updates
Recent updates
Shareholder Returns
| W8N | DE Biotechs | DE Market | |
|---|---|---|---|
| 7D | 0% | -1.6% | -0.5% |
| 1Y | -80.3% | -24.7% | 5.2% |
Return vs Industry: W8N underperformed the German Biotechs industry which returned -26.5% over the past year.
Return vs Market: W8N underperformed the German Market which returned -0% over the past year.
Price Volatility
| W8N volatility | |
|---|---|
| W8N Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 5.2% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 10.7% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: W8N's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine W8N's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 100 | Sylvia Wulf | www.aquabounty.com |
AquaBounty Technologies, Inc., a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. It engages in genetic, genomic, and fish health and nutrition research activities. The company also operates salmon farms using proprietary technology.
AquaBounty Technologies, Inc. Fundamentals Summary
| W8N fundamental statistics | |
|---|---|
| Market cap | €8.08m |
| Earnings (TTM) | -€23.01m |
| Revenue (TTM) | €2.16m |
3.7x
P/S Ratio-0.4x
P/E RatioIs W8N overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| W8N income statement (TTM) | |
|---|---|
| Revenue | US$2.37m |
| Cost of Revenue | US$15.03m |
| Gross Profit | -US$12.66m |
| Other Expenses | US$12.54m |
| Earnings | -US$25.20m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -6.55 |
| Gross Margin | -534.21% |
| Net Profit Margin | -1,063.23% |
| Debt/Equity Ratio | 4.9% |
How did W8N perform over the long term?
See historical performance and comparison